1. Perspectives on the risk of developing BRONJ and the risks and benefits of
bisphosphonates to facilitate medical decision-making of both the treating physician and the …

Purpose: This study compared two methods of preparing platelet-rich plasma (PRP) gel and
the levels of PDGF and TGFβ in each preparation. Materials and Methods: Platelet-rich …

PURPOSE: Bisphosphonates (BPs) are a widely used class of drugs that are effective in the
treatment and prevention of osteoporosis, hypercalcemia of malignancy, and bone …

… 1 , Thomas B Dodson, Leon A Assael, Regina Landesberg, Robert E Marx, Bhoomi
Mehrotra; Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American …

A potential side effect associated with bisphosphonates, a class of drugs used in the treatment
of osteoporosis, Paget's disease and metastatic bone disease, is osteonecrosis of the jaw …

PURPOSE: This study evaluates the temporal sequence and growth factor release from
platelet-rich plasma (PRP) combined with different bone substitutes (BS), to identify an optimal …

Osteonecrosis of the jaw (ONJ), a condition characterized by necrotic exposed bone in the
maxillofacial region, has been reported in a significant proportion of patients with cancer …

Bisphosphonates are used in the treatment of hypercalcemia of malignancy, skeletal
complications associated with metastastic bone disease, Paget's disease, and osteoporosis. …

The elimination of large zooplankton due to predation by fish was first described by Hrbacek
(1962) and thereafter by Brooks and Dodson (1965). Subsequently many other authors …

… Grbic DMD, MS, M Med Sc 1 1 , Regina Landesberg DMD, PhD 2 , Shou-Qing Lin MD 3 ,
Peter Mesenbrink PhD 4 , Ian R. Reid MD 5 , Ping-Chung Leung MD 6 , Noemi Casas MD 7 , …